T
TANGO THERAPEUTICS INC
NASDAQ: TNGX (Tango Therapeutics, Inc.)
最近更新时间: 4小时之前24.16
0.81 (3.47%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Tango Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.0
| 分析师共识 | NA |
| 内部交易活动 | -3.0 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.00 |
|
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 12.59% |
| 机构持股比例 | 97.41% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Rtw Investments, Lp | 30 Jun 2026 | 13,900,620 |
| Tcg Crossover Management, Llc | 30 Jun 2026 | 9,081,201 |
| Trv Gp Iv, Llc | 30 Jun 2026 | 6,374,574 |
| Paradigm Biocapital Advisors Lp | 30 Jun 2026 | 6,357,523 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| NEWCOMB JESSICA | - | 22.33 | -8,200 | -183,106 |
| 累积净数量 | -8,200 | |||
| 累积净值 ($) | -183,106 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 22.33 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| NEWCOMB JESSICA | 职员 | 22 Sep 2026 | 自动卖出 (-) | 8,200 | 22.33 | 183,106 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合